US 10426766
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
granted A61KA61K31/46A61K31/485
Quick answer
US patent 10426766 (Crystalline forms of an 8-azabicyclo[3.2.1]octane compound) held by Theravance Biopharma R&D IP, LLC expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/46, A61K31/485, A61K45/06, A61P